VTYX INVESTOR ALERT: Kirby McInerney LLP Alerts Ventyx Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit
18 avr. 2024 17h06 HE
|
Kirby McInerney LLP
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the upcoming April 30, 2024 deadline to seek the role of lead plaintiff in a federal securities...
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Regeneron Pharmaceuticals, Inc. (REGN)
18 avr. 2024 17h03 HE
|
Kirby McInerney LLP
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ:...
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Malibu Boats, Inc. (MBUU)
16 avr. 2024 17h13 HE
|
Kirby McInerney LLP
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Malibu Boats, Inc. (“Malibu” or the “Company”) (NASDAQ: MBUU). The...
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zoetis Inc. (ZTS)
15 avr. 2024 17h03 HE
|
Kirby McInerney LLP
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS). The investigation...
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Globe Life, Inc. (GL)
15 avr. 2024 16h39 HE
|
Kirby McInerney LLP
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Globe Life, Inc. (“Globe Life” or the “Company”) (NYSE: GL). The...
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against AXT, Inc. (AXTI)
08 avr. 2024 17h00 HE
|
Kirby McInerney LLP
NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against AXT, Inc. (“AXT” or the “Company”) (NASDAQ: AXTI). The investigation...
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Checkpoint Therapeutics, Inc. (CKPT) Investors
08 avr. 2024 16h51 HE
|
Kirby McInerney LLP
NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- (GLOBENEWSWIRE)—The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern...
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Autodesk, Inc. (ADSK)
03 avr. 2024 17h31 HE
|
Kirby McInerney LLP
NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Autodesk, Inc. (“Autodesk” or the “Company”) (NASDAQ:ADSK). The...
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zevra Therapeutics, Inc. (ZVRA)
02 avr. 2024 17h54 HE
|
Kirby McInerney LLP
NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Zevra Therapeutics, Inc. (“Zevra” or the “Company”) (NASDAQ: ZVRA). The...
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zymeworks Inc. (ZYME)
02 avr. 2024 17h52 HE
|
Kirby McInerney LLP
NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Zymeworks Inc. (“Zymeworks” or the “Company”) (NASDAQ: ZYME). The...